Skip to content

Author

Zhe-Sheng Chen

We have 10 of 227 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

From Structural Modification to Diverse Pharmacological Activities: Recent Advances and Future Perspectives of Bile Acids.

Bile acids (BAs) are amphiphilic steroid acids that exert a broad range of physiological effects-including the regulation of metabolism, immune responses, and inflammatory processes-through activation of specific receptors such as the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5). The...

Hong-Xia Zhu, He-Ming Chen, Qing-Jun Gong et al. · 0 citations
Open access Aug 2026

ELF3 (E74 like ETS transcription factor 3) promotes tumor growth and autophagy in pancreatic cancer

Despite the research progress of the past decades, the prognosis for pancreatic ductal adenocarcinoma remains poor. Identifying novel targets and exploring the underlying mechanisms is therefore of great importance. ELF3 (E74 like ETS transcription factor 3) is a member of the E-twenty-six (ETS) family and previo...

Yu-Ru Shang, Pingping Zhang, Yanhui Yang et al. · 0 citations
Review Open access Sep 2026

Itaconate and its derivatives in human health and diseases

Metabolic reprogramming forms the foundation of immune effector functions and the regulation of inflammation. As a pivotal node connecting the tricarboxylic acid cycle to immune signaling, the IRG1/ACOD1 and itaconate axes play a central role in coordinating inflammatory tone and redox balance. Itaconate, generated thr...

Jian-You Gu, Wen-Ying Zhang, Jun-Feng Zhang et al. · 0 citations
Open access Sep 2026

Senescent fibroblasts as drivers of malignant progression in gastric cancer.

Cancer-associated fibroblasts (CAFs) are key components of the tumor microenvironment and contribute substantially to gastric cancer progression. However, the phenotypic and functional heterogeneity of CAFs in gastric cancer remains incompletely characterized. Here, we analyzed single-cell transcriptomic data from gast...

Yu-Sheng Luo, L. Zhong, Ke-An Mu et al. · 0 citations
Review Open access Sep 2026

Hydrogel-driven construction of integrated cancer theranostic platforms: from diagnosis to therapy

Current cancer treatment still relies largely on stage-specific diagnosis and relatively fixed therapeutic regimens, while diagnostic information, therapeutic intervention, and efficacy feedback are often separated across different time windows. This fragmentation limits the ability to meet the demands of precision and...

Xuan-Ming Mao, Ming-Yu Cui, Lu-Qi Cao et al. · 1 citation
Open access Sep 2026

Berberine attenuates sepsis-associated myocardial injury and mitochondrial dysfunction through the AMPK/PGC-1α/NRF2 signaling pathway.

Mechanistic evidence is provided supporting Ber as a potential modulator of mitochondrial dysfunction during sepsis-associated myocardial injury and mitochondrial regulation as a potential target for further investigation and highlights mitochondrial regulation as a potential target for further investigation.

Ze-Lin Li, Ji-Hong Liu, Qi Shen et al. · 0 citations
Review Sep 2026

Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies.

A conceptual shift from conventional MDR models toward systemic adaptive resistance is proposed, and classical drug resistance, including drug uptake/efflux, compensatory pathway activation, and apoptosis evasion is reviewed.

Xiang Chen, Qin-Guo Huang, Ryan Li et al. · 0 citations
Review Open access Aug 2026

Drug resistance in cancer radiotherapy: from mechanisms to overcoming strategies.

This review outlines molecular, cellular, and microenvironmental adaptations in cancer RT that confer enhanced chemotherapy resistance in cancer cells surviving from ionizing radiation (IR), and summarizes mechanisms and emerging strategies for drug resistance in cancer RT.

Yang Chen, Chao-Yun Cai, Xiao-Cheng Xu et al. · 0 citations
Review Jul 2026

Antibody-Drug Conjugates Against Multidrug-Resistant Cancers: Biomarker-Guided Patient Selection, Payload Engineering, Linker Chemistry, and Bystander Effects.

A comprehensive analysis of the molecular structure of ADCs, the pharmacological principles underlying their potent cytotoxic activity against MDR cancer cells, the genomic and transcriptomic biomarkers that guide ADC patient selection, and the emerging resistance mechanisms that will shape the next generation of promi...

Ryan Li, Xiang Chen, Qin-Guo Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.